<?xml version='1.0' encoding='UTF-8'?><?xml-stylesheet type='text/xsl' href='https://www.aims-2-trials.eu/wp-content/plugins/google-sitemap-generator/sitemap.xsl'?><!-- sitemap-generator-url='http://www.arnebrachhold.de' sitemap-generator-version='4.1.23' -->
<!-- generated-on='April 15, 2026 3:37 pm' -->
<urlset xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' xsi:schemaLocation='http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd' xmlns='http://www.sitemaps.org/schemas/sitemap/0.9'>	<url>
		<loc>https://www.aims-2-trials.eu/2019/05/10/researchers-reach-out-to-the-autism-community/</loc>
		<lastmod>2019-12-18T13:06:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2019/07/03/autism-representatives-chosen-from-nearly-100-applications/</loc>
		<lastmod>2019-07-03T12:04:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2019/07/04/influence-research-across-europe/</loc>
		<lastmod>2019-07-09T12:23:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2019/08/20/machine-learning-heralds-a-new-era-for-autism-research/</loc>
		<lastmod>2020-03-20T11:57:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2019/09/24/eye-tracking-holds-clues-to-the-emergence-of-autism/</loc>
		<lastmod>2020-03-20T11:53:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2019/10/08/listen-to-declan-murphy-and-grainne-mcalonan-of-kcl-on-bbc-radio-4/</loc>
		<lastmod>2020-03-20T13:20:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2019/10/16/changing-pupil-size-indicates-social-abilities-in-autism/</loc>
		<lastmod>2020-03-20T11:48:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2019/11/12/other-events/</loc>
		<lastmod>2020-07-29T12:33:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2019/11/13/aims-2-trials-researchers-at-key-events-in-europe/</loc>
		<lastmod>2020-06-30T15:40:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2019/11/20/a-new-publication-for-autism-europe/</loc>
		<lastmod>2020-03-20T13:16:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2019/12/02/eu-aims-published-more-research-than-any-other-project-in-its-funding-call/</loc>
		<lastmod>2020-03-20T12:36:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2019/12/16/prestigious-scientific-awards-for-consortium-members/</loc>
		<lastmod>2020-03-20T12:32:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2020/02/10/2019-twin-study/</loc>
		<lastmod>2020-03-09T14:28:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2020/02/17/clinical-trials-begin-at-three-aims-2-trials-sites/</loc>
		<lastmod>2020-03-20T11:23:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2020/02/17/researcher-training-opportunities/</loc>
		<lastmod>2020-07-22T14:45:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2020/02/17/autism-representatives-a-reps/</loc>
		<lastmod>2020-07-29T12:31:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2020/02/25/want-to-get-involved/</loc>
		<lastmod>2020-07-08T11:07:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2020/03/20/machine-learning-heralds-a-new/</loc>
		<lastmod>2020-06-30T13:28:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2020/03/20/declan-murphy-grainne-mcalonan-of-kcl-on-bbc-radio-4/</loc>
		<lastmod>2020-06-30T15:48:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2020/03/24/eye-tracking-holds-clues/</loc>
		<lastmod>2020-06-30T13:27:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2020/03/24/changing-pupil-size/</loc>
		<lastmod>2020-06-30T13:27:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2020/03/24/clinical-trials-network/</loc>
		<lastmod>2020-06-30T13:26:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2020/03/24/autism-and-the-right-to-education-in-the-eu/</loc>
		<lastmod>2020-06-30T13:25:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2020/03/24/a-new-publication-for-autism-europe-2/</loc>
		<lastmod>2020-06-30T15:45:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2020/03/24/autistic-peoples-social-brain-activity-is-not-reduced/</loc>
		<lastmod>2020-07-22T10:20:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2020/03/24/eu-aims-published-more-research-2/</loc>
		<lastmod>2020-06-30T15:44:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2020/03/24/understanding-adaptive-functioning-in-autism/</loc>
		<lastmod>2020-06-30T13:24:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2020/03/24/prestigious-scientific-awards/</loc>
		<lastmod>2020-07-22T14:26:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2020/03/24/clinical-trials-begin/</loc>
		<lastmod>2020-06-30T13:16:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2020/03/24/eu-aims-published-more-research/</loc>
		<lastmod>2020-07-29T12:39:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2020/03/24/twin-study-shows-neurological-problems-are-associated-with-autism/</loc>
		<lastmod>2020-06-30T13:14:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2020/03/24/researcher-training-opportunities-2/</loc>
		<lastmod>2020-03-25T12:04:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2020/04/06/social-brain-activity/</loc>
		<lastmod>2020-04-07T07:59:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2020/04/27/13121/</loc>
		<lastmod>2020-04-30T10:55:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2020/05/07/understanding-adaptive-functioning/</loc>
		<lastmod>2020-05-07T11:07:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2020/06/04/elevated-likelihood-of-autism-and-adhd-influences-infants-motor-development/</loc>
		<lastmod>2020-06-04T13:30:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2020/06/30/elevated-likelihood-of-autism-and-adhd-influences-infants-motor-development-2/</loc>
		<lastmod>2020-06-30T13:12:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2020/07/16/eye_movements/</loc>
		<lastmod>2020-08-17T10:33:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2020/07/19/autistic-people-have-quicker-and-shorter-eye-movements-than-non-autistic-people/</loc>
		<lastmod>2020-07-21T15:10:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2020/07/20/aims-2-trials-response-to-covid-19/</loc>
		<lastmod>2020-07-21T15:09:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2020/07/28/autism-representatives-a-reps-2/</loc>
		<lastmod>2020-07-28T14:54:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2020/08/05/gene_alteration/</loc>
		<lastmod>2020-08-06T08:36:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2020/08/06/researcher-training-opportunities-3/</loc>
		<lastmod>2025-07-22T12:37:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2020/09/08/aims-2-trials-receives-favourable-feedback-from-european-medicines-agency/</loc>
		<lastmod>2020-09-08T12:54:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2020/09/08/cellular-memory-of-mothers-viral-infection-could-play-a-role-in-childs-later-brain-development/</loc>
		<lastmod>2020-09-15T16:40:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2020/09/16/escap/</loc>
		<lastmod>2021-06-29T10:52:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2020/10/07/quality_of_life/</loc>
		<lastmod>2021-05-10T14:44:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2020/10/13/biology-of-social-skills/</loc>
		<lastmod>2020-10-14T11:47:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2020/10/14/placebo-response/</loc>
		<lastmod>2021-05-10T14:44:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2020/11/09/professor_emily_jones_podcast/</loc>
		<lastmod>2020-11-09T12:02:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2020/11/17/new-analysis-technique-overcomes-limitations-in-recording-infant-brain-activity/</loc>
		<lastmod>2021-01-19T11:19:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2020/12/02/asymmetrical-brain-patterns-can-help-identify-subgroups-of-autistic-people/</loc>
		<lastmod>2021-01-20T10:31:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2020/12/08/autistic-people-focus-on-social-information-differently-to-non-autistic-people/</loc>
		<lastmod>2021-05-10T14:43:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2021/01/11/exploring_genetics_of_looking/</loc>
		<lastmod>2021-01-19T10:57:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2021/01/19/update-favourable-feedback-from-european-medicines-agency/</loc>
		<lastmod>2021-01-19T10:51:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2021/01/19/reduced-flexible-behaviour-in-autism-is-driven-by-less-optimal-learning/</loc>
		<lastmod>2021-01-27T09:36:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2021/01/19/new-database-developed-for-aims-2-trials-by-institut-pasteur/</loc>
		<lastmod>2021-05-26T15:10:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2021/02/07/german-tv-documentary-autismus-eine-welt-fur-sich-autism-a-world-of-its-own/</loc>
		<lastmod>2021-06-07T11:58:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2021/03/03/aims-2-trials-research-into-autism-subtypes-at-birkbeck/</loc>
		<lastmod>2021-06-24T09:54:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2021/03/10/are-there-differences-in-the-brains-of-autistic-men-and-women/</loc>
		<lastmod>2021-05-10T14:44:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2021/03/17/what-services-do-autistic-people-want-what-improvements-are-needed-time-to-let-policymakers-know/</loc>
		<lastmod>2021-03-17T12:47:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2021/03/17/what-do-autism-representatives-a-reps-do/</loc>
		<lastmod>2021-03-18T16:17:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2021/03/22/new-aims-2-trials-research-on-social-behaviour-in-the-mouse-brain-and-what-it-can-tell-us-about-autism/</loc>
		<lastmod>2021-05-10T14:42:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2021/04/12/attentivebrainstates/</loc>
		<lastmod>2021-05-26T13:59:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2021/04/21/professor-emily-jones-on-psychologicall-podcast/</loc>
		<lastmod>2021-04-23T09:17:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2021/04/27/study-of-screening-diagnosis-and-early-intervention-in-children-with-autism/</loc>
		<lastmod>2021-05-10T14:35:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2021/04/27/estudio-del-diagnostico-de-cribado-e-intervencion-temprana-en-ninos-con-autismo/</loc>
		<lastmod>2021-08-02T12:30:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2021/05/09/new-aims-2-trials-database-developed-by-institut-pasteur/</loc>
		<lastmod>2021-06-10T12:21:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2021/05/10/new-aims-2-trials-research-on-social-behaviour-in-the-mouse-and-what-it-can-tell-us-about-autism/</loc>
		<lastmod>2021-05-10T15:17:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2021/05/10/autistic-people-focus-on-social-information-differently-to-non-autistic-people-2/</loc>
		<lastmod>2021-05-10T15:16:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2021/05/10/understanding-placebo-response-in-clinical-trials-with-autistic-people/</loc>
		<lastmod>2021-06-10T12:18:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2021/05/10/how-quality-of-life-is-influenced-by-depression-and-anxiety-in-autism/</loc>
		<lastmod>2021-06-10T12:17:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2021/05/10/are-there-differences-in-the-brains-of-autistic-men-and-women-2/</loc>
		<lastmod>2021-06-10T12:16:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2021/05/10/professor-emily-jones-on-psychologicall-podcast-2/</loc>
		<lastmod>2021-06-07T16:05:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2021/05/10/cellular-memory-of-mothers-viral-infection-could-play-a-role-in-childs-later-brain-development-2/</loc>
		<lastmod>2021-06-10T12:14:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2021/05/10/early-career-reseracher-join-ecran/</loc>
		<lastmod>2025-07-22T12:38:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2021/05/10/sfn-2021/</loc>
		<lastmod>2021-06-07T14:41:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2021/05/12/european-society-of-child-and-adolescent-psychiatry-endorses-aims-2-trials-partner-publication/</loc>
		<lastmod>2021-06-07T08:24:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2021/05/17/distinct-behavioural-profiles-of-autism-matter/</loc>
		<lastmod>2021-05-18T15:00:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2021/05/18/covid-2/</loc>
		<lastmod>2021-05-19T10:10:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2021/05/19/reviewing-healthcare-barriers-for-autistic-people/</loc>
		<lastmod>2021-06-02T10:08:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2021/05/22/update-favourable-feedback-from-european-medicines-agency-2/</loc>
		<lastmod>2021-06-01T13:53:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2021/05/22/what-do-aims-2-trials-autism-representatives-a-reps-do/</loc>
		<lastmod>2021-05-26T16:01:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2021/05/22/whitepaper/</loc>
		<lastmod>2021-06-10T12:13:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2021/05/25/what-services-do-autistic-people-want-what-improvements-are-needed-time-to-let-policymakers-know-2/</loc>
		<lastmod>2021-06-10T12:45:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2021/05/26/reviewing-healthcare-barriers-for-autistic-people-2/</loc>
		<lastmod>2021-06-07T08:43:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2021/05/26/distinct-behavioural-profiles-of-autism-matter-2/</loc>
		<lastmod>2021-06-10T12:12:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2021/05/26/aims-2-trials-research-into-autism-subtypes-at-birkbeck-3/</loc>
		<lastmod>2021-06-11T12:27:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2021/05/26/attentive-brain-states-to-faces-in-infants-with-and-without-later-autism/</loc>
		<lastmod>2021-06-10T12:12:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2021/05/26/covid-exacerbates-healthcare-inequalities-for-autistic-people/</loc>
		<lastmod>2021-06-07T15:53:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2021/05/26/cited-researchers/</loc>
		<lastmod>2021-06-02T10:10:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2021/06/07/ecnp-congress/</loc>
		<lastmod>2021-06-08T13:34:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2021/06/07/british-association-for-psychopharmacology-2021-summer-meeting/</loc>
		<lastmod>2021-06-07T14:40:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2021/06/07/waimh-2021/</loc>
		<lastmod>2021-06-07T13:21:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2021/06/07/ohbm-2021/</loc>
		<lastmod>2021-06-08T13:32:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2021/06/07/spanish-association-for-child-and-adolescent-psychiatry/</loc>
		<lastmod>2021-06-07T12:27:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2021/06/07/eacd-european-academy-of-childhood-disability-20-may-2021/</loc>
		<lastmod>2021-06-07T16:36:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2021/06/07/insar/</loc>
		<lastmod>2021-06-10T12:23:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2021/06/28/aims-2-trials-innovations-are-among-those-selected-for-eu-innovation-radar-platform/</loc>
		<lastmod>2021-06-28T09:01:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2021/07/01/developing-wearable-technology-with-involvement-from-autistic-people/</loc>
		<lastmod>2021-07-01T13:26:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2021/07/05/infants-brain-activity-when-seeing-faces-is-written-in-their-dna/</loc>
		<lastmod>2021-11-15T11:24:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2021/08/02/impatto-economico-del-percorso-diagnostico-e-intervento-precoce-in-bambini-con-autismo/</loc>
		<lastmod>2021-08-02T12:36:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2021/11/16/closer-collaborations-needed-between-scientists-and-the-autistic-community/</loc>
		<lastmod>2022-01-27T13:45:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2021/12/14/attention-in-infants-is-linked-to-differences-in-biological-sex-and-socio-economic-status/</loc>
		<lastmod>2021-12-14T13:16:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2022/01/27/aims-2-trials-partners-involved-in-lancet-commission/</loc>
		<lastmod>2022-01-27T10:29:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2022/04/19/aims-2-trials-innovations-are-among-those-selected-for-eu-innovation-radar-platform-2/</loc>
		<lastmod>2022-04-19T16:46:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2022/04/19/developing-wearable-technology-with-involvement-from-autistic-people-2/</loc>
		<lastmod>2022-04-19T16:48:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2022/04/19/infants-brain-activity-when-seeing-faces-is-written-in-their-dna-2/</loc>
		<lastmod>2022-04-19T16:50:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2022/04/19/closer-collaborations-needed-between-scientists-and-the-autistic-community-2/</loc>
		<lastmod>2022-04-19T16:51:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2022/04/19/attention-in-infants-is-linked-to-differences-in-biological-sex-and-socio-economic-status-2/</loc>
		<lastmod>2022-04-19T16:53:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2022/04/19/aims-2-trials-partners-involved-in-lancet-commission-2/</loc>
		<lastmod>2022-04-19T16:53:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2022/04/29/variation-in-brain-structure-is-linked-to-changes-in-adaptive-behaviour-in-autistic-people/</loc>
		<lastmod>2022-05-03T11:33:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2022/05/19/variation-in-brain-structure-is-linked-to-changes-in-adaptive-behaviour-in-autistic-people-2/</loc>
		<lastmod>2022-05-19T15:26:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2022/05/19/insar-international-society-for-autism-research-may-2022/</loc>
		<lastmod>2022-05-19T15:40:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2022/05/31/the-value-of-treatment/</loc>
		<lastmod>2023-09-20T14:59:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2022/06/10/exploring-the-brain-biology-of-people-with-rare-genetic-conditions-related-to-autism/</loc>
		<lastmod>2022-06-10T14:34:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2022/06/13/exploring-the-brain-biology-of-people-with-rare-genetic-conditions-related-to-autism-2/</loc>
		<lastmod>2022-06-13T16:31:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2022/06/20/reviewing-the-evidence-for-medications-and-dietary-supplements-to-support-autistic-people/</loc>
		<lastmod>2022-06-20T08:25:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2022/12/14/work-package-updates-for-2022/</loc>
		<lastmod>2023-02-02T11:15:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2022/12/19/measuring-brain-activity-may-help-tailor-support-for-autistic-people/</loc>
		<lastmod>2022-12-19T13:38:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2022/12/19/recognising-faces-microstates/</loc>
		<lastmod>2022-12-19T14:31:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2023/03/29/understanding-autism-linking-genetics-brain-structure-and-behaviour/</loc>
		<lastmod>2023-03-29T09:31:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2023/04/20/autistic-people-may-pay-less-attention-to-faces-due-to-the-way-their-brains-process-sensory-information/</loc>
		<lastmod>2023-04-20T09:10:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2023/05/03/aims-2-trials-consultation-on-data-sharing/</loc>
		<lastmod>2023-05-03T15:04:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2023/07/11/studying-male-and-female-brains-do-they-differ-between-autistic-and-non-autistic-people/</loc>
		<lastmod>2023-07-11T12:55:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2023/08/02/new-project-european-autism-genomics-registry/</loc>
		<lastmod>2023-10-18T14:16:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2023/08/24/aims-2-trials-is-in-the-top-10-imi-projects-2/</loc>
		<lastmod>2023-08-24T14:21:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2023/10/18/bridging-the-gap-aims-2-trials-collaborators-advocate-for-neurodiversity-affirming-research/</loc>
		<lastmod>2023-10-18T12:51:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2024/02/05/more-than-meets-the-eye-art-competition/</loc>
		<lastmod>2025-03-25T13:17:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2024/02/15/autism-without-borders-award-event-2023/</loc>
		<lastmod>2024-05-30T09:38:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2024/05/31/what-can-we-learn-about-autism-in-adults-from-the-eye/</loc>
		<lastmod>2024-06-27T17:36:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2025/05/21/towards-a-common-approach-for-autism-in-europe-european-parliamentary-event/</loc>
		<lastmod>2025-05-21T15:25:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2026/03/10/roche-and-aims-2-trials-receives-eurordis-black-pearl-award-2026/</loc>
		<lastmod>2026-03-10T15:24:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.aims-2-trials.eu/2026/03/18/autistic-peoples-priorities-for-change-across-europe/</loc>
		<lastmod>2026-03-18T18:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
</urlset><!-- Request ID: 4dcea4df1f74b854eab307778be61307; Queries for sitemap: 7; Total queries: 83; Seconds: 0.02; Memory for sitemap: 1KB; Total memory: 117MB -->
